Clinical Trial Update: Almonertinib With Chemotherapy in mEGFR NSCLC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating almonertinib in combination with chemotherapy for metastatic non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Almonertinib (almonertinib)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Non-Small Cell Lung Cancer Metastatic | Phase 2 | Status: UNKNOWN